Litcius/Paper detail

New findings in the roles of Cyclin-dependent Kinase inhibitors 2B Antisense RNA 1 ( <i>CDKN2B-AS1</i> ) rs1333049 G/C and rs4977574 A/G variants on the risk to coronary heart disease

Wei Yuan, Wei Zhang, Wei Zhang, Zhongbao Ruan, Li Zhu, Yu Liu, Yuanyuan Mi, Lifeng Zhang

2020Bioengineered14 citationsDOIOpen Access PDF

Abstract

CDK: Cyclin Dependent Kinase; CCND: G1/S-specific cyclin-D; CDKN: Cyclin Dependent Kinase Inhibitor; GWAS: Genome-wide association study; CDKN2B-AS1: Cyclin-Dependent Kinase Inhibitors 2B Antisense RNA 1; CHD: Coronary heart disease; MAF: minor allele frequencies; HWE: Hardy-Weinberg equilibrium of controls; CI: confidence interval; COL8A2: Collagen type VIII alpha 2 chain; HB: Hospital-based; ORs: odds ratios; ITGA11: Integrin subunit alpha 11; LTBP: Latent transforming factor beta binding protein; PB: Population-based; IBC: Itmat Broad Care; NA: Not applicable; PCR-RFLP: polymerase chain reaction-restriction fragment length polymorphism; MI: Myocardial Infarction; SNP: single nucleotide polymorphism; SMAD: Mothers against decapentaplegic homolog; RT-PCR: Real-time polymerase chain reaction; UK: United Kingdom.

Topics & Concepts

Internal medicineAlleleCoronary artery diseaseOdds ratioMedicineOncologyCyclin-dependent kinaseBiologyGeneticsGeneCancerCell cycleRNA modifications and cancerCancer-related Molecular PathwaysFolate and B Vitamins Research
New findings in the roles of Cyclin-dependent Kinase inhibitors 2B Antisense RNA 1 ( <i>CDKN2B-AS1</i> ) rs1333049 G/C and rs4977574 A/G variants on the risk to coronary heart disease | Litcius